BioSpace News Archive

Transgene, a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined General Meeting of Transgene’s shareholders is available.

Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company.

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey and other members of the Executive Team will participate in a fireside chat during the 22nd Annual Needham Virtual Healthcare Conference.

Magnolia Medical Technologies, Inc., announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of 19 new Steripath® Micro configurations within the company’s ISDD® product portfolio.

OncoSec Medical Incorporated announced the closing of its previously announced registered direct offering of 1,582,932 shares of its common stock, at a purchase price of $1.25 per share, priced at-the-market under Nasdaq rules.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that Chinook management is scheduled to participate in the following upcoming investor conferences.

Perimeter Medical Imaging AI, Inc. reported financial results for the year ended December 31, 2022 and provided a corporate update.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX) today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation as part of the 22nd Annual Needham Healthcare Conference.

Trevi Therapeutics, Inc. today announced that Jennifer Good, President and Chief Executive Officer, Lisa Delfini, Chief Financial Officer, and David Clark, MD, Chief Medical Officer, will be participating in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, at 11:00 a.m. ET.